$SCYX
SCYNEXIS Inc

2022 Q4 Form 10-Q Financial Statement

#000095017022023822 Filed on November 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $1.524M $1.557M
YoY Change 155.28% 201.74%
Cost Of Revenue $196.0K $189.0K
YoY Change 17.37% 30.34%
Gross Profit $1.328M $1.368M
YoY Change 208.84% 268.73%
Gross Profit Margin 87.14% 87.86%
Selling, General & Admin $15.96M $16.74M
YoY Change 6.14% 8.62%
% of Gross Profit 1201.81% 1223.61%
Research & Development $7.849M $6.430M
YoY Change 2.07% 46.1%
% of Gross Profit 591.04% 470.03%
Depreciation & Amortization $155.0K $150.0K
YoY Change -36.99% 212.5%
% of Gross Profit 11.67% 10.96%
Operating Expenses $23.81M $23.36M
YoY Change 4.76% 17.9%
Operating Profit -$22.48M -$21.80M
YoY Change 0.83% 12.14%
Interest Expense $8.049M $1.379M
YoY Change -215.66% -92.66%
% of Operating Profit
Other Income/Expense, Net $3.000K -$7.783M
YoY Change -76.92% -141.43%
Pretax Income -$14.43M -$29.58M
YoY Change -50.66% 4416.64%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$14.43M -$29.58M
YoY Change -50.66% 4789.92%
Net Earnings / Revenue -946.78% -1900.06%
Basic Earnings Per Share -$0.62
Diluted Earnings Per Share -$0.30 -$0.62
COMMON SHARES
Basic Shares Outstanding 32.66M 32.65M
Diluted Shares Outstanding 47.50M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.50M $96.09M
YoY Change -29.65% -4.01%
Cash & Equivalents $45.81M $68.62M
Short-Term Investments $27.69M $27.47M
Other Short-Term Assets $62.00K $4.000K
YoY Change 1450.0% -98.92%
Inventory $899.0K $786.0K
Prepaid Expenses
Receivables $2.101M $2.493M
Other Receivables $0.00 $0.00
Total Short-Term Assets $79.06M $103.6M
YoY Change -27.72% -0.35%
LONG-TERM ASSETS
Property, Plant & Equipment $2.594M $2.646M
YoY Change 2195.58% -12.24%
Goodwill
YoY Change
Intangibles $408.0K $770.0K
YoY Change -61.36% -32.75%
Long-Term Investments
YoY Change
Other Assets $5.511M $5.076M
YoY Change -11.61% 183.73%
Total Long-Term Assets $8.749M $8.728M
YoY Change -16.36% 46.71%
TOTAL ASSETS
Total Short-Term Assets $79.06M $103.6M
Total Long-Term Assets $8.749M $8.728M
Total Assets $87.81M $112.3M
YoY Change -26.73% 2.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.937M $7.419M
YoY Change -24.35% -1.21%
Accrued Expenses $5.628M $5.856M
YoY Change -1.23% 27.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $17.62M $14.26M
YoY Change 29.39% 7.9%
LONG-TERM LIABILITIES
Long-Term Debt $45.39M $45.19M
YoY Change 12.5% 14.75%
Other Long-Term Liabilities $0.00 $4.898M
YoY Change -100.0% 133.35%
Total Long-Term Liabilities $0.00 $4.898M
YoY Change -100.0% 133.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.62M $14.26M
Total Long-Term Liabilities $0.00 $4.898M
Total Liabilities $84.58M $95.08M
YoY Change 7.63% 31.57%
SHAREHOLDERS EQUITY
Retained Earnings -$422.3M -$407.9M
YoY Change 17.48% 23.53%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.233M $17.21M
YoY Change
Total Liabilities & Shareholders Equity $87.81M $112.3M
YoY Change -26.73% 2.19%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$14.43M -$29.58M
YoY Change -50.66% 4789.92%
Depreciation, Depletion And Amortization $155.0K $150.0K
YoY Change -36.99% 212.5%
Cash From Operating Activities -$22.81M -$22.51M
YoY Change -10.63% 35.7%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$27.38M
YoY Change
Cash From Investing Activities $0.00 -$27.38M
YoY Change -100.0% 8000.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -183.0K
YoY Change -100.0% -104.04%
NET CHANGE
Cash From Operating Activities -22.81M -22.51M
Cash From Investing Activities 0.000 -27.38M
Cash From Financing Activities 0.000 -183.0K
Net Change In Cash -22.81M -50.07M
YoY Change -621.28% 304.09%
FREE CASH FLOW
Cash From Operating Activities -$22.81M -$22.51M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$22.81M -$22.51M
YoY Change -8.55% 38.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001178253
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36365
dei Entity Registrant Name
EntityRegistrantName
SCYNEXIS, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2181648
dei Entity Address Address Line1
EntityAddressAddressLine1
1 Evertrust Plaza
dei Entity Address Address Line2
EntityAddressAddressLine2
13th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Jersey City
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07302-6548
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
884-5485
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
SCYX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32656992
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68620000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104484000
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
27470000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4141000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3569000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2493000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
861000
CY2022Q3 us-gaap Inventory Net
InventoryNet
786000
CY2021Q4 us-gaap Inventory Net
InventoryNet
463000
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
55000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2022Q3 us-gaap Assets Current
AssetsCurrent
103565000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
109377000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5076000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6235000
CY2022Q3 us-gaap Deferred Costs
DeferredCosts
73000
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
150000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
163000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
218000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
770000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1056000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2646000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2801000
CY2022Q3 us-gaap Assets
Assets
112293000
CY2021Q4 us-gaap Assets
Assets
119837000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7419000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7848000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5856000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5698000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
720000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
269000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14264000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13616000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4898000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3345000
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
27730000
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
18062000
CY2022Q3 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
11032000
CY2021Q4 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
11607000
CY2022Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
34162000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
28745000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2998000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3204000
CY2022Q3 us-gaap Liabilities
Liabilities
95084000
CY2021Q4 us-gaap Liabilities
Liabilities
78579000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32656242
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32656242
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28705334
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28705334
CY2022Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
36000
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
32000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
425032000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
400705000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-407859000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-359479000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
17209000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1194000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41258000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
112293000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
119837000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1557000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
937000
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
531000
CY2021Q3 us-gaap Interest Income Other
InterestIncomeOther
8000
us-gaap Interest Income Other
InterestIncomeOther
724000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
516000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3567000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12566000
CY2022Q3 scyx Cost Of Product Revenues
CostOfProductRevenues
189000
CY2021Q3 scyx Cost Of Product Revenues
CostOfProductRevenues
145000
scyx Cost Of Product Revenues
CostOfProductRevenues
432000
scyx Cost Of Product Revenues
CostOfProductRevenues
145000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6430000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4401000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19410000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16083000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16739000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15411000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47001000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34879000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
23358000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
19957000
us-gaap Operating Expenses
OperatingExpenses
66843000
us-gaap Operating Expenses
OperatingExpenses
51107000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21801000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-19441000
us-gaap Operating Income Loss
OperatingIncomeLoss
-63276000
us-gaap Operating Income Loss
OperatingIncomeLoss
-38541000
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
CY2022Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
396000
CY2021Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
413000
us-gaap Interest Income Other
InterestIncomeOther
20000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1379000
CY2021Q3 us-gaap Interest Expense
InterestExpense
1019000
us-gaap Interest Expense
InterestExpense
3669000
us-gaap Interest Expense
InterestExpense
1678000
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
6497000
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-18810000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13215000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-35378000
CY2022Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-42000
CY2021Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1400000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1120000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1772000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47503821
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26616628
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40965908
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26147658
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47503821
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27754828
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40965908
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26326006
us-gaap Profit Loss
ProfitLoss
-48380000
us-gaap Profit Loss
ProfitLoss
-3623000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
451000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7783000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
18786000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10196000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
31830000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29584000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-655000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53080000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6711000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-50000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3088000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-29584000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-605000
us-gaap Net Income Loss
NetIncomeLoss
-48380000
us-gaap Net Income Loss
NetIncomeLoss
-3623000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.18
us-gaap Depreciation And Amortization
DepreciationAndAmortization
133000
us-gaap Share Based Compensation
ShareBasedCompensation
3232000
us-gaap Share Based Compensation
ShareBasedCompensation
1528000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
90000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1194000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
937000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13215000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-35378000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1120000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1772000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
155000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
149000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0
us-gaap Stock Issued1
StockIssued1
7452000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1729000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1271000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2425000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4990000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-57077000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29040000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
589000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
27380000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27389000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-589000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47248000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8027000
scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
3638000
scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
151000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
5000000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
30000000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
26000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
1253000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
18000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
22000
scyx Payments For Proceeds From Repurchase Of Shares To Satisfy Tax Withholdings
PaymentsForProceedsFromRepurchaseOfSharesToSatisfyTaxWithholdings
-0
scyx Payments For Proceeds From Repurchase Of Shares To Satisfy Tax Withholdings
PaymentsForProceedsFromRepurchaseOfSharesToSatisfyTaxWithholdings
3000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48602000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36642000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-35864000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7013000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104702000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93314000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68838000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100327000
us-gaap Interest Paid Net
InterestPaidNet
3308000
us-gaap Interest Paid Net
InterestPaidNet
1569000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
636000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
18000
us-gaap Stock Issued1
StockIssued1
0
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
556000
scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
0
scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
50000
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
77000
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
30000
scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
71000
scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
298000
scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
206000
scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
390000
scyx Settlement Of Liability For Exercise Of Warrants
SettlementOfLiabilityForExerciseOfWarrants
0
scyx Settlement Of Liability For Exercise Of Warrants
SettlementOfLiabilityForExerciseOfWarrants
805000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-407900000
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
96100000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1138200
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-29584000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-605000
us-gaap Net Income Loss
NetIncomeLoss
-48380000
us-gaap Net Income Loss
NetIncomeLoss
-3623000
CY2022Q3 scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
0
CY2021Q3 scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
-0
scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
0
scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
-15719000
CY2022Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
CY2021Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-988000
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-29584000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1593000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-48380000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-19342000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47503821
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26616628
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40965908
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26147658
CY2022Q3 scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
0
CY2021Q3 scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
0
scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
0
scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
178348
CY2022Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47503821
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27754828
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40965908
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26326006
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27100846
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20473931
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27100846
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15172265
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:3.933%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassification of Prior Year Amounts</span></p><p style="text-indent:3.933%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain prior year amounts have been reclassified for consistency with the current year presentation.</span></p>
CY2022Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
27470000
CY2022Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0
CY2022Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
164000
CY2022Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
27306000
CY2022Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
27500000
CY2022Q3 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
857000
CY2021Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
247000
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
543000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
505000
CY2022Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2737000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2813000
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
4000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4141000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3569000
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5331000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5162000
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
0
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
56000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
127000
CY2022Q3 scyx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
5387000
CY2021Q4 scyx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
5292000
CY2022Q3 scyx Debt Instrument Final Fee Due At Maturity
DebtInstrumentFinalFeeDueAtMaturity
1383000
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
36383000
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2022Q3 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
783000
CY2021Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
1498000
CY2022Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1821000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2012000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2580000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1352000
CY2022Q3 scyx Accrued Rebates Current
AccruedRebatesCurrent
672000
CY2021Q4 scyx Accrued Rebates Current
AccruedRebatesCurrent
836000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5856000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5698000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
23684000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
11316000
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
35000000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2221000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
34162000
CY2022Q3 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-42000
CY2021Q3 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
1400000
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
1900000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7300000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company has the option to renew for two consecutive five-year periods from the end of the first term and the Company is not reasonably certain that the option to renew the Lease will be exercised. Under the Lease, the Company furnished a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which was reduced by fifty-five thousand dollars on the first anniversary of the commencement date. The security deposit will continue to be reduced by fifty-five thousand dollars every two years on the commencement date anniversary for eight years.
CY2018Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
us-gaap Operating Lease Cost
OperatingLeaseCost
498000
us-gaap Operating Lease Cost
OperatingLeaseCost
498000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
8000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
9000
us-gaap Variable Lease Cost
VariableLeaseCost
13000
us-gaap Variable Lease Cost
VariableLeaseCost
18000
CY2022Q3 us-gaap Lease Cost
LeaseCost
174000
CY2021Q3 us-gaap Lease Cost
LeaseCost
175000
us-gaap Lease Cost
LeaseCost
511000
us-gaap Lease Cost
LeaseCost
516000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
118000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
116000
us-gaap Operating Lease Payments
OperatingLeasePayments
350000
us-gaap Operating Lease Payments
OperatingLeasePayments
343000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y10M2D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M2D
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
177000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
715000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
730000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
744000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
759000
CY2022Q3 scyx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2030000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5155000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
269000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2998000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3267000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3267000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1888000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32656242
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32656242
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28705334
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28705334
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
45480000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-29584000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1210000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8000
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
95000
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
17209000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
32320000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-605000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
588000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
13000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5301000
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-3000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
37614000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41258000
us-gaap Net Income Loss
NetIncomeLoss
-48380000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
323200
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
18000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21010000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
71000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
17209000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
22758000
us-gaap Net Income Loss
NetIncomeLoss
-3623000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1528000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
22000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8713000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-3000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
766000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
37614000
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
42158758
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14367493
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
6500000
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-18800000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13200000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-35400000
CY2022Q3 scyx Fair Value Of Liabilities
FairValueOfLiabilities
27700000
CY2021Q4 scyx Fair Value Of Liabilities
FairValueOfLiabilities
18100000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1542126
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.89
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M12D
CY2021Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3059000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
664000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
81124
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.42
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2125002
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.82
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M9D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
49000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1052080
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
18.11
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2125002
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
11.82
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y7M9D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
49000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000000.0
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3100000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1500000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2022Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1037000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
588000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1528000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1380000
scyx Contract With Customer Liability Provision Related To Current Period Revenue
ContractWithCustomerLiabilityProvisionRelatedToCurrentPeriodRevenue
4160000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
24000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3724000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1840000

Files In Submission

Name View Source Status
0000950170-22-023822-index-headers.html Edgar Link pending
0000950170-22-023822-index.html Edgar Link pending
0000950170-22-023822.txt Edgar Link pending
0000950170-22-023822-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-20220930.htm Edgar Link pending
scyx-20220930.xsd Edgar Link pending
scyx-ex10_1.htm Edgar Link pending
scyx-ex10_2.htm Edgar Link pending
scyx-ex31_1.htm Edgar Link pending
scyx-ex31_2.htm Edgar Link pending
scyx-ex32_1.htm Edgar Link pending
scyx-ex3_4.htm Edgar Link pending
Show.js Edgar Link pending
scyx-20220930_def.xml Edgar Link unprocessable
scyx-20220930_lab.xml Edgar Link unprocessable
scyx-20220930_pre.xml Edgar Link unprocessable
scyx-20220930_htm.xml Edgar Link completed
scyx-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable